Clinical trial
Efficacy and Safety of Tegileridine on Postoperative Pain in Adolescent Patients Undergoing Scoliosis Correction Surgery: A Multicentre, Double-blind, Non-inferiority, Randomised Controlled Trial
NCT07229495 is registered in ClinicalTrials.gov with Peking Union Medical College Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Tegileridine on Postoperative Pain in Adolescent Patients Undergoing Scoliosis Correction Surgery: A Multicentre, Double-blind, Non-inferiority, Randomised Controlled Trial
- Lead sponsor
- Peking Union Medical College Hospital
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- April 8, 2026
- Completion date
- December 30, 2027
- Enrollment
- 171 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
analgesia, patient-controlled, pain after surgery, scoliosis; adolescence